Drug Efficacy Analytics

Finding the right anti-epileptic drug (AED) is critical for improving patient outcomes and driving business success in the pharmaceutical industry. Up to 70% of epilepsy patients can achieve seizure control with the right medication, making drug effectiveness a key factor for both healthcare providers and pharma companies.

Our interactive dashboard enables pharma executives, R&D professionals, and healthcare strategists to compare long-acting (LA) vs. short-acting (SA) AED monotherapy in terms of healthcare utilization, patient adherence, and cost efficiency. By leveraging advanced data analytics for pharma, this solution helps businesses optimize drug strategies, improve market positioning, and accelerate data-driven decision-making.